Autoantibodies against bestrophin in a patient with vitelliform paraneoplastic retinopathy and a metastatic choroidal malignant melanoma.
Eksandh
Louise
L
Adamus
Grazyna
G
Mosgrove
Lori
L
Andréasson
Sten
S
D001323:Autoantibodies / Q000097:blood*; D000075002:Bestrophins; D014408:Biomarkers, Tumor / Q000276:immunology; D018118:Chloride Channels / Q000276:immunology*; D002830:Choroid Neoplasms / Q000473:pathology*; D004268:DNA-Binding Proteins / Q000276:immunology; D004585:Electrooculography; D005136:Eye Proteins / Q000276:immunology*; D006801:Humans; D008113:Liver Neoplasms / Q000556:secondary; D008175:Lung Neoplasms / Q000556:secondary; D008297:Male; D008545:Melanoma / Q000556:secondary*; D008875:Middle Aged; D010257:Paraneoplastic Syndromes / Q000175:diagnosis / Q000276:immunology*; D010751:Phosphopyruvate Hydratase / Q000276:immunology; D012164:Retinal Diseases / Q000175:diagnosis / Q000276:immunology*; D041623:Tomography, Optical Coherence; D025521:Tumor Suppressor Proteins / Q000276:immunology; D014794:Visual Fields
D001323:Autoantibodies; C113133:BEST1 protein, human; D000075002:Bestrophins; D014408:Biomarkers, Tumor; D018118:Chloride Channels; D004268:DNA-Binding Proteins; D005136:Eye Proteins; D025521:Tumor Suppressor Proteins; C095157:ENO1 protein, human; D010751:Phosphopyruvate Hydratase